162 related articles for article (PubMed ID: 2141048)
1. The activated keratinocyte: a model for inducible cytokine production by non-bone marrow-derived cells in cutaneous inflammatory and immune responses.
Kupper TS
J Invest Dermatol; 1990 Jun; 94(6 Suppl):146S-150S. PubMed ID: 2141048
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory and hyperproliferative skin disease in mice that express elevated levels of the IL-1 receptor (type I) on epidermal keratinocytes. Evidence that IL-1-inducible secondary cytokines produced by keratinocytes in vivo can cause skin disease.
Groves RW; Rauschmayr T; Nakamura K; Sarkar S; Williams IR; Kupper TS
J Clin Invest; 1996 Jul; 98(2):336-44. PubMed ID: 8755642
[TBL] [Abstract][Full Text] [Related]
3. Cytokine modulation of keratinocyte cytokines.
Ansel J; Perry P; Brown J; Damm D; Phan T; Hart C; Luger T; Hefeneider S
J Invest Dermatol; 1990 Jun; 94(6 Suppl):101S-107S. PubMed ID: 2161884
[TBL] [Abstract][Full Text] [Related]
4. Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin.
Nickoloff BJ; Naidu Y
J Am Acad Dermatol; 1994 Apr; 30(4):535-46. PubMed ID: 7512582
[TBL] [Abstract][Full Text] [Related]
5. [Adhesion molecules and inflammatory dermatoses].
Viac J; Schmitt D; Claudy A
Allerg Immunol (Paris); 1994 Oct; 26(8):274-7. PubMed ID: 7802927
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor-alpha induces interleukin-1 alpha and interleukin-1 receptor antagonist production by cultured human keratinocytes.
Kutsch CL; Norris DA; Arend WP
J Invest Dermatol; 1993 Jul; 101(1):79-85. PubMed ID: 8331299
[TBL] [Abstract][Full Text] [Related]
7. IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-gamma and TNF-alpha.
Albanesi C; Cavani A; Girolomoni G
J Immunol; 1999 Jan; 162(1):494-502. PubMed ID: 9886425
[TBL] [Abstract][Full Text] [Related]
8. Cytokine induction in human epidermal keratinocytes exposed to contact irritants and its relation to chemical-induced inflammation in mouse skin.
Wilmer JL; Burleson FG; Kayama F; Kanno J; Luster MI
J Invest Dermatol; 1994 Jun; 102(6):915-22. PubMed ID: 8006454
[TBL] [Abstract][Full Text] [Related]
9. Keratinocytes as initiators of inflammation.
Barker JN; Mitra RS; Griffiths CE; Dixit VM; Nickoloff BJ
Lancet; 1991 Jan; 337(8735):211-4. PubMed ID: 1670850
[TBL] [Abstract][Full Text] [Related]
10. A review of the roles of keratinocyte-derived cytokines and chemokines in the pathogenesis of atopic dermatitis in humans and dogs.
Asahina R; Maeda S
Vet Dermatol; 2017 Feb; 28(1):16-e5. PubMed ID: 27426268
[TBL] [Abstract][Full Text] [Related]
11. The role of chronic inflammation in cutaneous fibrosis: fibroblast growth factor receptor deficiency in keratinocytes as an example.
Meyer M; Müller AK; Yang J; Ŝulcová J; Werner S
J Investig Dermatol Symp Proc; 2011 Dec; 15(1):48-52. PubMed ID: 22076327
[TBL] [Abstract][Full Text] [Related]
12. Keratinocyte-specific deletion of the receptor RAGE modulates the kinetics of skin inflammation in vivo.
Leibold JS; Riehl A; Hettinger J; Durben M; Hess J; Angel P
J Invest Dermatol; 2013 Oct; 133(10):2400-2406. PubMed ID: 23594597
[TBL] [Abstract][Full Text] [Related]
13. Accumulation of C-reactive protein in basal keratinocytes of normal skins.
Ono K; Fujimoto N; Akiyama M; Satoh T; Tajima S
J Dermatol Sci; 2016 Jul; 83(1):26-33. PubMed ID: 27150021
[TBL] [Abstract][Full Text] [Related]
14. Oncostatin M secreted by skin infiltrating T lymphocytes is a potent keratinocyte activator involved in skin inflammation.
Boniface K; Diveu C; Morel F; Pedretti N; Froger J; Ravon E; Garcia M; Venereau E; Preisser L; Guignouard E; Guillet G; Dagregorio G; Pène J; Moles JP; Yssel H; Chevalier S; Bernard FX; Gascan H; Lecron JC
J Immunol; 2007 Apr; 178(7):4615-22. PubMed ID: 17372020
[TBL] [Abstract][Full Text] [Related]
15. Cytokine-mediated effects of peripheral blood mononuclear cells from patients with atopic eczema on keratinocytes (HaCaT) in a new coculture system.
Neuber K; Steinrücke K; Kowalzick L; Köhler I; Ring J
Br J Dermatol; 1995 Nov; 133(5):750-6. PubMed ID: 8555028
[TBL] [Abstract][Full Text] [Related]
16. Role of keratinocyte-derived cytokines in chemical toxicity.
Luster MI; Wilmer JL; Germolec DR; Spalding J; Yoshida T; Gaido K; Simeonova PP; Burleson FG; Bruccoleri A
Toxicol Lett; 1995 Dec; 82-83():471-6. PubMed ID: 8597097
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-17 is produced by both Th1 and Th2 lymphocytes, and modulates interferon-gamma- and interleukin-4-induced activation of human keratinocytes.
Albanesi C; Scarponi C; Cavani A; Federici M; Nasorri F; Girolomoni G
J Invest Dermatol; 2000 Jul; 115(1):81-7. PubMed ID: 10886512
[TBL] [Abstract][Full Text] [Related]
18. Epidermal keratinocytes initiate wound healing and pro-inflammatory immune responses following percutaneous schistosome infection.
Bourke CD; Prendergast CT; Sanin DE; Oulton TE; Hall RJ; Mountford AP
Int J Parasitol; 2015 Mar; 45(4):215-24. PubMed ID: 25575749
[TBL] [Abstract][Full Text] [Related]
19. Impaired IFN-gamma-dependent inflammatory responses in human keratinocytes overexpressing the suppressor of cytokine signaling 1.
Federici M; Giustizieri ML; Scarponi C; Girolomoni G; Albanesi C
J Immunol; 2002 Jul; 169(1):434-42. PubMed ID: 12077274
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiology of cutaneous inflammation.
Nickoloff BJ
Arch Dermatol Res; 1992; 284 Suppl 1():S10-1. PubMed ID: 1285650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
